Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer (Q85125251)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20890743%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20890743%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

Matthias Guckenberger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20890743%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Bülent Polat

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20890743%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

5

Michael Flentje

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20890743%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Sami Ok

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20890743%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Reinhart A Sweeney

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20890743%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

30 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20890743%20AND%20SRC:MED&resulttype=core&format=json

Strahlentherapie und Onkologie

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20890743%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

186

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20890743%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20890743%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

535-543

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20890743%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00066-010-2144-z

14 February 2020

exact match

0 references

cites work

Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer

1 reference

12 December 2020

Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes

1 reference

12 December 2020

Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRT.

1 reference

12 December 2020

Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only?

1 reference

12 December 2020

Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy

1 reference

12 December 2020

No impairment of quality of life 18 months after high-dose intensity-modulated radiotherapy for localized prostate cancer: a prospective study.

1 reference

12 December 2020

Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer

1 reference

12 December 2020

Comment by J. Schäfer, G. Welzel, F. Wenz on D. Norkus et al. A randomized trial comparing hypofractionated and conventionally fractionated three-dimensional external-beam radiotherapy for localized prostate adenocarcinoma. a report on acute toxicit

1 reference

12 December 2020

Acute toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated intensity-modulated radiotherapy.

1 reference

12 December 2020

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer

1 reference

12 December 2020

Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer

1 reference

12 December 2020

Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial

1 reference

12 December 2020

Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer.

1 reference

12 December 2020

Duration of androgen suppression in the treatment of prostate cancer

1 reference

12 December 2020

Precision of image-guided radiotherapy (IGRT) in six degrees of freedom and limitations in clinical practice.

1 reference

12 December 2020

Low-grade toxicity after conformal radiation therapy for prostate cancer--impact of bladder volume.

1 reference

12 December 2020

Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer

1 reference

12 December 2020

Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial

1 reference

12 December 2020

The sensitivity of dose distributions for organ motion and set-up uncertainties in prostate IMRT

1 reference

12 December 2020

Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413

1 reference

12 December 2020

Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking

1 reference

12 December 2020

Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area

1 reference

12 December 2020

Long-term androgen deprivation increases Grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapy

1 reference

12 December 2020

Intensity-modulated radiotherapy (IMRT) of localized prostate cancer: a review and future perspectives.

1 reference

12 December 2020

Clinical Toxicities and Dosimetric Parameters After Whole-Pelvis Versus Prostate-Only Intensity-Modulated Radiation Therapy for Prostate Cancer

1 reference

12 December 2020

Acute symptoms, not rectally administered sucralfate, predict for late radiation proctitis: longer term follow-up of a phase III trial--Trans-Tasman Radiation Oncology Group

1 reference

12 December 2020

Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy

1 reference

12 December 2020

Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991

1 reference

12 December 2020

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

1 reference

12 December 2020

Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: results from the Dutch trial of 68 GY versus 78 Gy.

1 reference

12 December 2020

An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions

1 reference

12 December 2020

High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients

1 reference

12 December 2020

Late GI and GU complications in the treatment of prostate cancer

1 reference

12 December 2020

Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer

1 reference

12 December 2020

Fractionation and late rectal toxicity

1 reference

12 December 2020

A randomized trial comparing hypofractionated and conventionally fractionated three-dimensional external-beam radiotherapy for localized prostate adenocarcinoma : a report on acute toxicity

1 reference

12 December 2020

Application of the No Action Level (NAL) protocol to correct for prostate motion based on electronic portal imaging of implanted markers

1 reference

12 December 2020

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

1 reference

12 December 2020

Dosimetric comparison of image guidance by megavoltage computed tomography versus bone alignment for prostate cancer radiotherapy

1 reference

12 December 2020

Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy.

1 reference

12 December 2020

Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01.

1 reference

12 December 2020

A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer

1 reference

12 December 2020

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

1 reference

12 December 2020

Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial

1 reference

12 December 2020

Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion.

1 reference

12 December 2020

Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage

1 reference

12 December 2020

Clinical Application of High-Dose, Image-Guided Intensity-Modulated Radiotherapy in High-Risk Prostate Cancer

1 reference

12 December 2020

Acute toxicity of whole-pelvis IMRT in 87 patients with localized prostate cancer

1 reference

12 December 2020

Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer.

1 reference

12 December 2020

Dose-volume effects for normal tissues in external radiotherapy: pelvis

1 reference

12 December 2020

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

12 December 2020